A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
Humans are protected against infection from most African trypanosomes by lipoprotein complexes present in serum that contain the trypanolytic pore-forming protein, Apolipoprotein L1 (APOL1). The human-infective trypanosomes, Trypanosoma brucei rhodesiense in East Africa and T. b. gambiense in West A...
Saved in:
Main Authors: | Anneli Cooper (Author), Paul Capewell (Author), Caroline Clucas (Author), Nicola Veitch (Author), William Weir (Author), Russell Thomson (Author), Jayne Raper (Author), Annette MacLeod (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
by: Paul Capewell, et al.
Published: (2011) -
Association of APOL1 renal disease risk alleles with Trypanosoma brucei rhodesiense infection outcomes in the northern part of Malawi.
by: Kelita Kamoto, et al.
Published: (2019) -
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
by: Andrew P Jackson, et al.
Published: (2010) -
Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.
by: Vincent Jamonneau, et al.
Published: (2012) -
Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteins.
by: Liesbeth Carolien Van Nieuwenhove, et al.
Published: (2011)